We are live on ! Find out more
VNDA icon

Vanda Pharmaceuticals

109 hedge funds and large institutions have $571M invested in Vanda Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 32 increasing their positions, 34 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

331% more call options, than puts

Call options by funds: $56.9M | Put options by funds: $13.2M

267% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 9

45% more capital invested

Capital invested by funds: $393M → $571M (+$178M)

27% more funds holding

Funds holding: 86109 (+23)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

6% less repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 34

Holders
109
Holders Change
+23
Holders Change %
+26.74%
% of All Funds
3.15%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
33
Increased
32
Reduced
34
Closed
9
Calls
$56.9M
Puts
$13.2M
Net Calls
+$43.7M
Net Calls Change
+$24.8M
Name Holding Trade Value Shares
Change
Change in
Stake
Citadel Advisors
51
Citadel Advisors
Florida
$1.15M -$4.42M -311,118 -82%
AllianceBernstein
52
AllianceBernstein
Tennessee
$1.14M +$385K +27,113 +63%
California Public Employees Retirement System
53
California Public Employees Retirement System
California
$1.1M
SFM
54
Sphera Funds Management
Israel
$1.06M -$427K -30,000 -32%
TD Asset Management
55
TD Asset Management
Ontario, Canada
$983K +$189K +13,300 +28%
California State Teachers Retirement System (CalSTRS)
56
California State Teachers Retirement System (CalSTRS)
California
$980K +$5.69K +400 +0.7%
ProShare Advisors
57
ProShare Advisors
Maryland
$962K +$600K +42,187 +248%
GPCM
58
Granite Point Capital Management
Massachusetts
$936K +$819K +57,600 New
TA
59
Teachers Advisors
New York
$821K +$58K +4,080 +9%
TCM
60
Timpani Capital Management
Wisconsin
$800K +$700K +49,227 New
WMSA
61
Weiss Multi-Strategy Advisers
New York
$786K -$23.3K -1,640 -3%
Charles Schwab
62
Charles Schwab
California
$769K
QIM
63
Quantitative Investment Management
Virginia
$721K +$631K +44,400 New
Prudential Financial
64
Prudential Financial
New Jersey
$714K +$1.42K +100 +0.2%
State Board of Administration of Florida Retirement System
65
State Board of Administration of Florida Retirement System
Florida
$671K -$8.67K -610 -1%
ACM
66
Atika Capital Management
New York
$618K +$540K +38,000 New
ST
67
Spot Trading
Illinois
$584K +$178K +12,544 +54%
BA
68
BlackRock Advisors
Delaware
$533K -$403K -28,329 -46%
Wells Fargo
69
Wells Fargo
California
$516K -$8.96M -630,316 -95%
CI
70
Cowen Inc
New York
$488K +$71.1K +5,000 +20%
LTFS
71
Ladenburg Thalmann Financial Services
Florida
$474K -$11.7K -825 -3%
RhumbLine Advisers
72
RhumbLine Advisers
Massachusetts
$463K -$18.2K -1,280 -4%
Barclays
73
Barclays
United Kingdom
$461K -$4.26M -299,569 -91%
LP
74
LMR Partners
United Kingdom
$447K +$391K +27,505 New
GCP
75
GSA Capital Partners
United Kingdom
$447K +$392K +27,538 New

VNDA Hedge Fund Activity: Q1 2014 in Review

109 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Vanda Pharmaceuticals (VNDA) for Q1 2014, worth a combined $571M — up 45% from $393M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new VNDA positions and 9 closed out — a net gain of 24 holders — while 32 added to existing stakes and 34 trimmed.

The largest buyer was Paulson & Co, opening a new position worth an estimated $19.8M. The largest seller was Millennium Management, cutting an estimated $9.65M.

  • 109 institutional investors held Vanda Pharmaceuticals (VNDA) as of Q1 2014, up from 86 in Q4 2013.
  • Funds reported $571M of Vanda Pharmaceuticals stock for Q1 2014, up 45% quarter-over-quarter.
  • 33 funds opened new Vanda Pharmaceuticals positions in Q1 2014 and 9 closed out, a net change of +24 holders.
  • The largest Vanda Pharmaceuticals buyer in Q1 2014 was Paulson & Co, an estimated $19.8M added.
  • The largest Vanda Pharmaceuticals seller in Q1 2014 was Millennium Management, an estimated $9.65M sold.

Based on aggregated 13F filings for Q1 2014.